The U.S. Food and Drug Administration (FDA) Nov. 19 approved Navigator for treating equine protozoal myeloencephalitis (EPM). This drug has been under development for more than six years. IDEXX ...
Have you ever wished you could pull all the scientific recommendations on equine protozoal myeloencephalitis (EPM) diagnosis and treatment together in one place? Done! At the 2009 American Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback